Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Amdocs stock

Learn how to easily invest in Amdocs stock.

Amdocs Ltd
+ $1.14 ( + 1.37%)

Amdocs Ltd is a software-infrastructure business based in the US. Amdocs shares (DOX) are listed on the NASDAQ and all prices are listed in US Dollars. Amdocs employs 30,000 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Amdocs

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – DOX – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Amdocs stock price (NASDAQ: DOX)

Use our graph to track the performance of DOX stocks over time.

Amdocs shares at a glance

Information last updated 2022-07-01.
Latest market close$84.45
52-week range$67.36 - $87.76
50-day moving average $82.36
200-day moving average $78.48
Wall St. target price$90.50
PE ratio 18.8926
Dividend yield $1.475 (1.9%)
Earnings per share (TTM) $4.47

Buy Amdocs shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
Finder Award
Stocks, ETFs, Cryptocurrency
when you sign up and deposit $100
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, or TN.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Axos Bank Self Directed Investing
when you open an account and deposit at least $1500.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Amdocs stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Amdocs price performance over time

Historical closes compared with the close of $84.45 from 2022-07-01

1 week (2022-06-28) 1.34%
1 month (2022-06-03) -2.86%
3 months (2022-04-01) N/A
6 months (2022-01-05) 13.36%
1 year (2021-07-02) 7.72%
2 years (2020-07-02) 40.70%
3 years (2019-07-05) 34.39%
5 years (2017-07-03) 31.28%

Is Amdocs stock undervalued or overvalued?

Valuing Amdocs stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Amdocs's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Amdocs's P/E ratio

Amdocs's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 19x. In other words, Amdocs shares trade at around 19x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Amdocs's PEG ratio

Amdocs's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.0911. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Amdocs's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Amdocs's EBITDA

Amdocs's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $841.6 million.

The EBITDA is a measure of a Amdocs's overall financial performance and is widely used to measure a its profitability.

Amdocs financials

Revenue TTM $4.4 billion
Operating margin TTM 14.38%
Gross profit TTM $1.5 billion
Return on assets TTM 6.01%
Return on equity TTM 15.5%
Profit margin 12.76%
Book value $28.99
Market capitalisation $10.4 billion

TTM: trailing 12 months

Amdocs's environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Amdocs.

When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.

Amdocs's total ESG risk score

Total ESG risk: 20.97

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Amdocs's overall score of 20.97 (as at 12/31/2018) is pretty good – landing it in it in the 21st percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like Amdocs is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

Amdocs's environmental score

Environmental score: 6.71/100

Amdocs's environmental score of 6.71 puts it squarely in the 6th percentile of companies rated in the same sector. This could suggest that Amdocs is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

Amdocs's social score

Social score: 15.33/100

Amdocs's social score of 15.33 puts it squarely in the 6th percentile of companies rated in the same sector. This could suggest that Amdocs is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

Amdocs's governance score

Governance score: 10.44/100

Amdocs's governance score puts it squarely in the 6th percentile of companies rated in the same sector. That could suggest that Amdocs is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

Amdocs's controversy score

Controversy score: 1/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. Amdocs scored a 1 out of 5 for controversy – the highest score possible, reflecting that Amdocs has managed to keep its nose clean.

Environmental, social, and governance (ESG) summary

Amdocs Ltd was last rated for ESG on: 2019-01-01.

Total ESG score 20.97
Total ESG percentile 20.5
Environmental score 6.71
Environmental score percentile 6
Social score 15.33
Social score percentile 6
Governance score 10.44
Governance score percentile 6
Level of controversy 1

Amdocs share dividends


Dividend payout ratio: 28.76% of net profits

Recently Amdocs has paid out, on average, around 28.76% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.9% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Amdocs shareholders could enjoy a 1.9% return on their shares, in the form of dividend payments. In Amdocs's case, that would currently equate to about $1.475 per share.

While Amdocs's payout ratio might seem fairly standard, it's worth remembering that Amdocs may be investing much of the rest of its net profits in future growth.

Amdocs's most recent dividend payout was on 28 July 2022. The latest dividend was paid out to all shareholders who bought their shares by 28 June 2022 (the "ex-dividend date").

Amdocs share price volatility

Over the last 12 months, Amdocs's shares have ranged in value from as little as $67.3641 up to $87.758. A popular way to gauge a stock's volatility is its "beta".

DOX.US volatility(beta: 0.71)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Amdocs's is 0.711. This would suggest that Amdocs's shares are less volatile than average (for this exchange).

Amdocs overview

Amdocs Limited, through its subsidiaries, provides software and services worldwide. The company designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. It provides CES21, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; the Commerce and Care suite for order capture, handling, and customer engagement; the Monetization suite for charging, billing, policy, and revenue management; Intelligent Networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; MarketONE, a cloud-native business ecosystem; Digital Brands Suite, a pre-integrated digital business suite for digital telecom brands and small-scale service providers; and eSIM Cloud for service providers. It also offers AI-powered, cloud-native, and home operating systems; data intelligence solutions and applications; media services for media publishers, TV networks, and video streaming and service providers; end-to-end application development and maintenance services; and ongoing services. In addition, the company provides a line of services designed for various stages of a service provider's lifecycle includes design, delivery, quality engineering, operations, systems integration, mobile network services, consulting, and content services; managed services comprising application development, modernization and maintenance, IT and infrastructure services, testing and professional services that are designed to assist customers in the selection, implementation, operation, management, and maintenance of IT systems. It serves to the communications, cable and satellite, entertainment, and media industry service providers, as well as mobile virtual network operators and directory publishers. Amdocs Limited was founded in 1988 and is headquartered in Saint Louis, Missouri.

Frequently asked questions

What percentage of Amdocs is owned by insiders or institutions?
Currently 0.058% of Amdocs shares are held by insiders and 98.492% by institutions.
How many people work for Amdocs?
Latest data suggests 30,000 work at Amdocs.
When does the fiscal year end for Amdocs?
Amdocs's fiscal year ends in September.
Where is Amdocs based?
Amdocs's address is: 625 Maryville Centre Drive, Saint Louis, MO, United States, 63141
What is Amdocs's ISIN number?
Amdocs's international securities identification number is: GB0022569080
What is Amdocs's CUSIP number?
Amdocs's Committee on Uniform Securities Identification Procedures number is: G02602103

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site